-
Loading metrics
Open Access
Peer-reviewed
Research Article
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
-
Yana Pikman,
Affiliation Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Benjamin H Lee,
Affiliation Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Thomas Mercher,
Affiliation Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Elizabeth McDowell,
Affiliation Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Benjamin L Ebert,
Affiliations Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America , Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America
⨯ -
Maricel Gozo,
Affiliation Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Adam Cuker,
Affiliation Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Gerlinde Wernig,
Affiliation Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Sandra Moore,
Affiliation Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Ilene Galinsky,
Affiliation Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Daniel J DeAngelo,
Affiliation Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Jennifer J Clark,
Affiliation Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Stephanie J Lee,
Affiliation Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
Todd R Golub,
Affiliations Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America , Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America , Howard Hughes Medical Institute, Boston, Massachusetts, United States of America
⨯ -
Martha Wadleigh,
Affiliation Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ -
D. Gary Gilliland,
Affiliations Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America , Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America , Howard Hughes Medical Institute, Boston, Massachusetts, United States of America
⨯ - [ ... ],
-
Ross L Levine
*To whom correspondence should be addressed. E-mail: ross_levine@dfci.harvard.edu
Affiliations Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America , Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America
⨯ - [ view all ]
- [ view less ]
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
- Yana Pikman,
- Benjamin H Lee,
- Thomas Mercher,
- Elizabeth McDowell,
- Benjamin L Ebert,
- Maricel Gozo,
- Adam Cuker,
- Gerlinde Wernig,
- Sandra Moore,
- Ilene Galinsky
- Published: July 18, 2006
- https://doi.org/10.1371/journal.pmed.0030270